1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Clinical trial of psilocybin for Alcohol Use Disorder (AUD) & PTSD (PsiloStudy) is sponsored by State of Washington (awarded to Center for Novel Therapeutics in Addiction Psychiatry at University of Washington). This study, funded by the State of Washington, investigates the safety and feasibility of using psilocybin, administered with psychological support, to treat veterans and first responders with co-occurring PTSD and Alcohol Use Disorder.
Get alerted about grants like this
Save a search for “State of Washington (awarded to Center for Novel Therapeutics in Addiction Psychiatry at University of Washington)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Psilocybin clinical trial for Alcohol Use Disorder & PTSD: PsiloStudy – Center for Novel Therapeutics in Addiction Psychiatry Psilocybin clinical trial for Alcohol Use Disorder & PTSD: PsiloStudy In May 2023, Governor Jay Inslee signed Senate Bill 5263 into law, which mandated a study into psilocybin as well as the creation of a regulatory body for the possible recreational and medical use of the drug.
This first-of-its-kind study will explore the safety and effectiveness of psilocybin to treat alcohol use disorder (AUD) and for post-traumatic stress disorder (PTSD). Leading the study is Dr. Nathan Sackett , an addiction psychiatrist with the University of Washington’s Department of Psychiatry and Behavioral Sciences.
PsiloStudy (NCT06853912) is enrolling a small cohort of veterans and first responders who have both alcohol use disorder (AUD) and PTSD to be treated with psilocybin and psychological support (Psi-PS). Eligible individuals will be in stable general health, willing to undergo psychedelic treatment, and agree to adhere to the treatment protocol – including up to 6 months of follow-up visits.
Eligible individuals who finish the study can receive up to $550 for their time. Rigorous screening measures are in place to ensure that it is safe for each person to participate. This study is open to recruitment as of February 28, 2025.
Interested individuals are encouraged to complete the pre-screen questionnaire by clicking the link or scanning the QR code below: Study Pre-Screen Survey: https://redcap. link/psilostudy Scan here with your smartphone camera: Webpage updated: March 18, 2025
According to the current listing, eligibility includes: Veterans and first responders with both PTSD and Alcohol Use Disorder. (Study is actively recruiting participants.). Confirm the full requirements in the official notice before applying.
Clinical trial of psilocybin for Alcohol Use Disorder (AUD) & PTSD (PsiloStudy) is funded by State of Washington (awarded to Center for Novel Therapeutics in Addiction Psychiatry at University of Washington). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleDARPA and NSF launched a joint program on June 1 to fund university work on AI interpretability, control, and adversarial robustness. Awards run $750K to $3M+ per project, the forum launches this summer, and the universities listed in the AI Forge repository will sit closest to the money. The Request for Information closes June 22.
Read articleOn June 1, 2026, DARPA and the National Science Foundation announced AI Forge — a jointly governed forum that will fund, guide, and manage university-led research on AI interpretability, AI control, and adversarial robustness. The RFI on sam.gov closes June 22. The forum itself will be administered by a new nonprofit launching in summer 2026. The structure is what matters: this is not a one-off solicitation, it is a multi-year venue for university-government-industry research that operates outside the normal merit-review timelines of either agency. What university research teams should be doing in the seventeen-day window between the announcement and the RFI deadline — and what the forum model means for federal AI funding through FY 2028.
Read article